Clinical Trial Update: Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the safety and efficacy of omalizumab for allergic asthma across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Shanghai Zhangjiang Biotechnology Limited Company | Conditions: Allergic Asthma | Phase 2, Phase 3 | Status: COMPLETED